| Literature DB >> 31356129 |
Emmanouil S Brilakis1, Kambis Mashayekhi2, Etsuo Tsuchikane3, Nidal Abi Rafeh4, Khaldoon Alaswad5, Mario Araya6, Alexandre Avran7, Lorenzo Azzalini8, Avtandil M Babunashvili9, Baktash Bayani10, Ravinay Bhindi11, Nicolas Boudou12, Marouane Boukhris13, Nenad Ž Božinović14, Leszek Bryniarski15, Alexander Bufe16, Christopher E Buller17, M Nicholas Burke1, Heinz Joachim Büttner2, Pedro Cardoso18, Mauro Carlino8, Evald H Christiansen19, Antonio Colombo20, Kevin Croce21, Felix Damas de Los Santos22, Tony De Martini23, Joseph Dens24, Carlo Di Mario25, Kefei Dou26, Mohaned Egred27, Ahmed M ElGuindy28,29, Javier Escaned30, Sergey Furkalo31, Andrea Gagnor32, Alfredo R Galassi33, Roberto Garbo34, Junbo Ge35, Pravin Kumar Goel36, Omer Goktekin37, Luca Grancini38, J Aaron Grantham39, Colm Hanratty40, Stefan Harb41, Scott A Harding42, Jose P S Henriques43, Jonathan M Hill44, Farouc A Jaffer45, Yangsoo Jang46, Risto Jussila47, Artis Kalnins48, Arun Kalyanasundaram49, David E Kandzari50, Hsien-Li Kao51, Dimitri Karmpaliotis52, Hussien Heshmat Kassem53,54, Paul Knaapen55, Ran Kornowski56, Oleg Krestyaninov57, A V Ganesh Kumar58, Peep Laanmets59, Pablo Lamelas60,61, Seung-Whan Lee62, Thierry Lefevre63, Yue Li64, Soo-Teik Lim65, Sidney Lo66, William Lombardi67, Margaret McEntegart68, Muhammad Munawar69, José Andrés Navarro Lecaro70, Hung M Ngo71, William Nicholson72, Göran K Olivecrona73, Lucio Padilla74, Marin Postu75, Alexandre Quadros76, Franklin Hanna Quesada77, Vithala Surya Prakasa Rao78, Nicolaus Reifart79, Meruzhan Saghatelyan80, Ricardo Santiago81, George Sianos82, Elliot Smith83, James C Spratt84, Gregg W Stone85, Julian W Strange86, Khalid Tammam87, Imre Ungi88, Minh Vo89, Vu Hoang Vu90, Simon Walsh40, Gerald S Werner91, Jason R Wollmuth92, Eugene B Wu93, R Michael Wyman94, Bo Xu95, Masahisa Yamane96, Luiz F Ybarra97, Robert W Yeh98, Qi Zhang99, Stephane Rinfret100.
Abstract
Outcomes of chronic total occlusion (CTO) percutaneous coronary intervention (PCI) have improved because of advancements in equipment and techniques. With global collaboration and knowledge sharing, we have identified 7 common principles that are widely accepted as best practices for CTO-PCI. 1. Ischemic symptom improvement is the primary indication for CTO-PCI. 2. Dual coronary angiography and in-depth and structured review of the angiogram (and, if available, coronary computed tomography angiography) are key for planning and safely performing CTO-PCI. 3. Use of a microcatheter is essential for optimal guidewire manipulation and exchanges. 4. Antegrade wiring, antegrade dissection and reentry, and the retrograde approach are all complementary and necessary crossing strategies. Antegrade wiring is the most common initial technique, whereas retrograde and antegrade dissection and reentry are often required for more complex CTOs. 5. If the initially selected crossing strategy fails, efficient change to an alternative crossing technique increases the likelihood of eventual PCI success, shortens procedure time, and lowers radiation and contrast use. 6. Specific CTO-PCI expertise and volume and the availability of specialized equipment will increase the likelihood of crossing success and facilitate prevention and management of complications, such as perforation. 7. Meticulous attention to lesion preparation and stenting technique, often requiring intracoronary imaging, is required to ensure optimum stent expansion and minimize the risk of short- and long-term adverse events. These principles have been widely adopted by experienced CTO-PCI operators and centers currently achieving high success and acceptable complication rates. Outcomes are less optimal at less experienced centers, highlighting the need for broader adoption of the aforementioned 7 guiding principles along with the development of additional simple and safe CTO crossing and revascularization strategies through ongoing research, education, and training.Entities:
Keywords: coronary occlusion; methods; outcome; percutaneous coronary intervention; treatment
Mesh:
Year: 2019 PMID: 31356129 DOI: 10.1161/CIRCULATIONAHA.119.039797
Source DB: PubMed Journal: Circulation ISSN: 0009-7322 Impact factor: 29.690